Anne O’Kearney-McMullan

ORCID: 0000-0002-8026-9426
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Innovative Microfluidic and Catalytic Techniques Innovation
  • Asymmetric Hydrogenation and Catalysis
  • Chemical Synthesis and Analysis
  • Oxidative Organic Chemistry Reactions
  • Synthesis and Catalytic Reactions
  • Catalytic Processes in Materials Science
  • Chemistry and Chemical Engineering
  • Computational Drug Discovery Methods
  • Synthesis and Biological Evaluation
  • Analytical Chemistry and Chromatography
  • Crystallization and Solubility Studies
  • Process Optimization and Integration
  • Synthesis of Indole Derivatives
  • Marine Toxins and Detection Methods
  • Cyclization and Aryne Chemistry
  • Marine Sponges and Natural Products
  • Nanomaterials for catalytic reactions
  • Estrogen and related hormone effects
  • Microfluidic and Capillary Electrophoresis Applications
  • Machine Learning in Materials Science
  • Catalytic Cross-Coupling Reactions
  • Pharmacogenetics and Drug Metabolism
  • Synthesis and Reactions of Organic Compounds
  • Analytical chemistry methods development
  • Synthetic Organic Chemistry Methods

AstraZeneca (United Kingdom)
2013-2024

AstraZeneca (Brazil)
2019-2020

Macclesfield College
2019-2020

Medicines Evaluation Unit
2011

AstraZeneca (India)
2004

The American Chemical Society (ACS) Green Chemistry Institute (GCI) Pharmaceutical Roundtable conducted a study to elucidate the value of continuous processing, which had been defined as key research area for green engineering. In course defining business case individual cases were collected and evaluated determine specific drivers implement processing find success factors. magnitude timing effects relation principles chemistry investigated.

10.1021/op400245s article EN Organic Process Research & Development 2013-11-21

The development of a continuous flow sulfoxide imidation protocol for pharmaceutically relevant target molecule is described. Sulfoxide key step in the preparation certain ATR kinase inhibitors. Reactions with NaN3 or TMSN3 and concentrated sulfuric acid under literature conditions provided low conversions poor selectivities. In contrast, reactions employing fuming afforded sulfoximine selectivity ∼90% after reaction time only 10–15 min at 50 °C. using as reagent was successfully performed...

10.1021/acs.oprd.5b00217 article EN Organic Process Research & Development 2015-07-23

AZD6738 is currently being tested in multiple phase I/II trials for the treatment of cancer. Its structure, comprising a pyrimidine core decorated with chiral morpholine, cyclopropyl sulfoximine, and an azaindole, make it challenging molecule to synthesize on large scale. We describe evolution chemical processes, following manufacture from initial scale-up through multikilos plant During this evolution, we developed biocatalytic process install sulfoxide high enantioselectivity, followed by...

10.1021/acs.oprd.9b00075 article EN Organic Process Research & Development 2019-06-21

For on-line monitoring of chemical reactions (batch or continuous flow), mass spectrometry (MS) can provide data to (1) determine the fate starting materials and reagents, (2) confirm presence desired product, (3) identify intermediates impurities, (4) steady state conditions point completion, (5) speed up process optimization. Recent developments in small footprint atmospheric pressure ionization portable spectrometers further enable this coupling, as spectrometer be easily positioned with...

10.1007/s13361-014-0957-1 article EN Journal of the American Society for Mass Spectrometry 2014-08-08

A safe and scalable continuous flow strategy for Wolff–Kishner reductions that employs methanol as the solvent has been developed. The use of low-cost hydrazine reducing agent in combination with a caustic base provides an atom-efficient, environmentally friendly method deoxygenation aldehydes ketones to alkanes. Because required harsh corrosive reaction conditions (200 °C, 50 bar), reactor materials such stainless steel, glass, or any type polymer have compatibility problems, rendering this...

10.1021/acs.oprd.9b00336 article EN Organic Process Research & Development 2019-10-07

A definitive screening design (DSD) combined with reaction profiling was conducted using a flow reactor, in short time frame, for the accurate estimation of kinetic parameters.

10.1039/c9re00180h article EN Reaction Chemistry & Engineering 2019-01-01

Abstract A continuous‐flow protocol for Pd‐catalyzed olefin cleavage by using molecular oxygen as the sole oxidant to give carbonyl compounds was explored. The developed flow allowed use of a low catalyst loading (0.1 mol %), and decomposition active prevented through stabilization poly(ethylene glycol)‐400 (PEG‐400), which present cosolvent. Radical scavengers inhibited reaction, indicated involvement free‐radical path in reaction mechanism. applicability demonstrated on several substrates....

10.1002/cctc.201700671 article EN ChemCatChem 2017-05-09

The development of a continuous flow ruthenium-catalyzed ester reduction using hydrogen gas is described. assessment green metrics show the protocol substantially more sustainable than commonly employed metal hydride reductions.

10.1039/d0gc02225j article EN cc-by-nc Green Chemistry 2020-01-01

The development of a commercial manufacturing process for fulvestrant (the active ingredient in 'Faslodex') is described. Key steps the synthesis are stereoselective 1,6-addition an organocuprate to steroidal dienone followed by copper-mediated aromatisation A-ring. strategy dealing with noncrystalline intermediates outlined. production drug substance acceptable quality critically dependent on limiting formation key impurities. origin these impurities discussed, and measures prevent or control their

10.1021/op900315j article EN Organic Process Research & Development 2010-03-29

Key steps in the synthesis of ZM549865 (a 5-HT receptor antagonist) are palladium-catalysed amination ethyl 8-bromo-6-fluoro-4-oxo-4H-2-chromenecarboxylate and subsequent hydrolysis ester group. The development a simple, robust process capable making multikilogram amounts required intermediate is described. Performing step at 125 °C instead 80 optimising conditions led to an increase overall yield from 44% about 70% as well reducing reaction time days hours. chromone ring was initially...

10.1021/op0499369 article EN Organic Process Research & Development 2004-09-16

ADVERTISEMENT RETURN TO ISSUEEditorialNEXTFlow Chemistry and Continuous Processing: More Mainstream than Ever!Kevin P. Cole*Kevin ColeSynthetic Molecule Design Development, Lilly Research Laboratories, Eli Company, Indianapolis, Indiana 46285, United States*Email: [email protected]More by Kevin Colehttps://orcid.org/0000-0002-2333-6557, Jonathan N. JaworskiJonathan JaworskiProcess Takeda Pharmaceuticals International Co., 35 Landsdowne Street, Cambridge, Massachusetts 02139, StatesMore...

10.1021/acs.oprd.3c00483 article EN other-oa Organic Process Research & Development 2024-05-17

Abstract The spiroketal moiety is an important substructure within many biological natural products. One method to access them via the oxidative cyclisation of a pendant hydroxyl group on pre‐formed pyran. However applications this methodology have been severely limited by requiring use toxic oxidants, such as lead (IV) tetraacetate or mercuric oxide. Herein we report high yielding photochemical route prepare complex spiroketals using approach employing iodine monochloride and sodium acetate...

10.1002/adsc.202400393 article EN cc-by Advanced Synthesis & Catalysis 2024-07-23

The development of a continuous-flow sequence for the synthesis an important drug candidate precursor is reported. Abediterol β2-adrenoceptor agonist that has undergone phase IIa clinical trials treatment respiratory disease. A flow developed preparation lipophilic amine tail portion abediterol. comprises phase-transfer-catalyzed liquid/liquid O-alkylation, rhodium-catalyzed hydroformylation, and ruthenium-catalyzed reductive amination. reactions were optimized separately within environments...

10.1021/acs.oprd.1c00002 article EN cc-by Organic Process Research & Development 2021-03-08

In a previous publication (Org. Process Res. Dev. 2010, 14, DOI:10.1021/op100161y) we described the process research and development of manufacturing route for potent SRC kinase inhibitor AZD0530. While was successfully used to manufacture 4.5 kg AZD0530 difumarate, it still relatively long, two Mitsunobu couplings, was, in our opinion, undesirable on larger scale. Herein describe shorter, more practical synthesis difumarate. The new route, which required fewer steps, scaled well produce >80...

10.1021/op100163m article EN Organic Process Research & Development 2010-08-23

Abstract The spiroketal moiety is an important substructure within many biological natural products. One method to access them via the oxidative cyclisation of a pendant hydroxyl group on pre‐formed pyran. However such precursors has hitherto been challenging and requires multistep syntheses frequently with considerable protecting manipulation. Herein we report novel high yielding for preparation hydroxydi‐ hydroxytetra‐hydropyrans, as precursors, utilizing double‐Prins approach.

10.1002/ejoc.202200810 article EN European Journal of Organic Chemistry 2022-09-21

Abstract On treatment with formamides and POCl 3 , the title compounds produce benzoxazinone structures.

10.1002/chin.201215177 article EN ChemInform 2012-03-15
Coming Soon ...